ChiRhoStim
Drug Diagnostic
NDC 67066-005-01
General payments
$12,600
Research payments
$265,589
Through program year 2025, $12,600 in general payments and $265,589 in research payments were reported against ChiRhoStim (Diagnostic).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $89,964 | 2 |
| 2022 | Research | $21,275 | 5 |
| 2021 | Research | $27,300 | 3 |
| 2020 | Research | $37,800 | 5 |
| 2019 | General | $12,600 | 1 |
| 2019 | Research | $89,250 | 10 |
Breakdown
Each share is of general payments naming this product in 2019.
Each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2019 where a state was reported.
Records
1 general · 25 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.